Carolyn J. Henry
Associate Professor, Oncology
Office Address: 373A Clydesdale Hall
Mailing Address:

379 E. Campus Drive , Department of Veterinary Medicine & Surgery, College of Veterinary Medicine , UMC, Columbia , MO 65211

Phone: (573)-882-7821
Fax: (573)-884-5444
Email: HenryC@missouri.edu
URL:

http://www.vmth.missouri.edu/

Education:

1994

 DACVIM Medical Oncology, American College of Veterinary Internal Medicine, Lakewood, CO
1993 MS Small Animal Surgery/Medicine, Auburn University, Auburn, AL
1990 DVM Veterinary Medicine, Auburn University, Auburn, AL
1987 BS Animal Science/Biology Eastern Kentucky University, Richmond, KY
Professional Experience:

2003-Present

 Associate Professor of Oncology
2002-present Director, Tom and Betty Scott Endowed Program in Veterinary Oncology, University of Missouri-Columbia
2001-present Assistant Professor, Oncology, Internal Medicine, Hematology/Oncology, School of Medicine (dual appt), University of Missouri-Columbia
1997-present Assistant Professor, Oncology, Veterinary Medicine and Surgery, University of Missouri-Columbia
1993-1997 Assistant Professor, tenure track, Veterinary Clinical Sciences, Washington State University, Pullman, WA
1992-1993 Emergency Care Veterinarian, part-time, Columbus Animal Emergency Center, Columbus, GA.
1991-1993 Oncology Resident/MS Candidate, Small Animal Surgery and Medicine, Veterinary Medicine, Auburn University.
1990-1991 Associate Veterinarian, Animal Care Center, Prattville, AL.
1991-1993 Emergency Care Veterinarian, part-time, Montgomery AL. Animal Emergency Clinic
Recent Publications:
  1. Henry CJ, Buss MS, Hellstrom I, Hellstrom KE, Brewer WG, Bryan JN, Siegall CB. Clinical evaluation of BR96 sFv-PE40 immunotoxin therapy in canine models of spontaneously occurring invasive carcinomas. Clin Cancer Res 2005;11:751-5.
  2. Bryan JN, Fang J, Mohsin, J, Sivaguru G, Miller WH, Anderson CJ, Henry CJ, Lewis MR. Comparative uptakes and biodistributions of internalizing versus non-internalizing copper-64 radioimmunoconjugates in cell and animal models of colon cancer. Nucl Med Biol 2005;32(8):851-8.
  3. Chun R, Garrett LD, Henry CJ, Wall M, Smith A. Cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma. J Am Anim Hosp Assoc 2005; 41:382-7.
  4. Bryan JN, Jia F, Mohsin, J, Sivaguru G, Miller WH, Anderson CJ, Henry CJ, Lewis MR. Comparative uptakes and biodistributions of internalizing versus non-internalizing copper-64 radioimmunoconjugates in cell and animal models of colon cancer. Nucl Med Biol 2005;32(8):851-8.
  5. Henry CJ, Brewer WG, Whitley EM, Tyler JW. Ogilvie GK. Norris A. Fox LE. Morrison WB. Hammer A. Vail DM. Berg J et al. Canine digital tumors: A Veterinary Cooperative Oncology Group retrospective study of 64 cases. J Vet Internal Med 2005;19:720-4.
  6. Bryan, JN, Henry CJ, Turnquist SE, Tyler JW, Liptak J, Rizzo S, Sfiligoi G, Steinberg HS, Smith AN, Jackson T. Primary renal neoplasia of dogs: a retrospective review of 82 cases. J Vet Internal Med, 2006;20:1155-1160.
  7. McCaw DL, Chan AS, Stegner AL, Mooney B, Bryan JN, Turnquist SE, Henry CJ, Alexander H, Alexander S. Proteomics of canine lymphoma identifies potential cancer specific protein markers. Clin Cancer Res 2007;13:2496-2503.
  8. Bryan JN, Keeler MR, Henry CJ, Bryan ME, Hahn AW, Caldwell CW. A population study of neutering status as a risk factor for canine prostate cancer. The Prostate 2007;67:1174-1181
  9. Johnson KD, Glinskii OV, Mossine VV, Turk JR, Mawhinney TP, Anthony DC, Henry CJ, Huxley VH, Glinsky GV, Pienta KJ, Raz A, Glinsky VV. Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelium. Neoplasia 2007;9:662-670.
  10. Henry CJ, Downing S, Rosenthal RC, Klein MK, Meleo K, Villamil JA, Fineman LS, McCaw DL, Higginbotham ML, McMichael, J. Evaluation of a novel immunomodulator composed of human chorionic gonadotropin and bacillus Calmette-Guerin for treatment of canine mast cell tumors in clinically affected dogs. Am J Vet Res 2007;68:1246-1251.
  11. Johannes CM, Henry CJ, Turnquist SE, Hamilton T, Smith AN, Chun R, Tyler JW. Feline hemangiosarcoma: A retrospective study of 53 cases. J Am Vet Med Assoc 2007, in press.
  12. Rankin WV, Henry CJ, Turnquist SE, Turk JR, Beissenherz ME, Tyler JW, Green JA, Rucker EB, Rodriguez CO, Knapp DW. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma. J Vet Comp Oncol, in press.
  13. Rankin WV, Henry CJ, Turnquist SE, Turk JR, Beissenherz ME, Tyler JW, Green JA. Evaluation of survivin, an inhibitor of apoptosis, in canine urinary bladder cystitis tissues. Am J Vet Res, in press
  14. Bryan JN, Taylor KH, Henry CJ, Selting KA, Rahmatpanah F, Lewis MR, Caldwell CW. DNA Methylation in Cancer: techniques and preliminary evidence of hypermethylation in a canine gene. Cancer Therapy 2008, in press.
  15. Henry CJ, McCaw DL, Turnquist SE, Tyler JW, Bravo L, Sheafor S, Straw RC, Dernell WS, Madewell BR, Jorgensen L, Scott MA, Higginbotham ML, Chun R. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma. Clinical Cancer Research 2003;9:906-911.
  16. Higginbotham ML, Henry CJ, Katti KV, Casteel SW, Dowling PM, Pillarsetty N. Preclinical tolerance and pharmacokinetic assessment of MU-Gold, a novel chemotherapeutic agent, in laboratory dogs. Vet Therapeutics 2003;4:76-82.
  17. Henry CJ. Management of transitional cell carcinoma. Vet Clinics of North America Small Anim Prac 2003;33:597-613.
  18. Henry CJ, Tyler JW, McEntee MC, Stokol T, Rogers KS, Chun R, Garrett LD, McCaw DL, Higginbotham ML, Flessland KA, Stokes PK. Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs. Am J Vet Research 2003;64(8):1017-1020.
  19. Moore AS , Nelson RW, Henry CJ, et al. A diuresis protocol for administration of streptozotocin to dogs with pancreatic islet cell tumors. J Am Vet Med Assoc 2002;221(6):811-818.
  20. Fox DB, Cook JL, Kreeger JM, Beissenherz M, Henry CJ. Canine synovial sarcoma: a retrospective assessment of described prognostic criteria in 16 cases. J Am Anim Hosp Assoc 2002;38:347-355.
  21. Clifford CA, Hughes D, Beal MW, Henry CJ, et al. Vascular endothelial growth factor concentrations in body cavity effusions in dogs. J Vet Int Med 2002;164-168.

 

Copyright © 2006 — Curators of the University of Missouri.
All rights reserved. DMCA and other copyright information.
An equal opportunity/affirmative action institution.
Please send all questions and comments to the Webmaster
Last updated on 5/9/04